HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Abe Selected Research

Adenoma (Adenomas)

2/2008Diagnosis of aldosterone producing adenomas.
8/2001Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
9/2000Does prolactin releasing peptide receptor regulate prolactin-secretion in human pituitary adenomas?
8/2000Magnetic resonance imaging of a non-pigmented adenoma of the ciliary epithelium.
1/2000Histopathological and physiological characteristics of cultured human ACTH-secreting cells derived from a rapidly growing pituitary adenoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Abe Research Topics

Disease

35Neoplasms (Cancer)
11/2014 - 01/2000
9Stomach Neoplasms (Stomach Cancer)
11/2020 - 02/2000
9Hemorrhage
12/2008 - 02/2000
9Glioma (Gliomas)
10/2003 - 01/2000
8Infections
06/2017 - 12/2000
8Aneurysm (Aneurysms)
11/2011 - 11/2000
7Lung Neoplasms (Lung Cancer)
01/2005 - 05/2000
7Macular Degeneration (Age-Related Maculopathy)
12/2001 - 03/2000
6Carcinoma (Carcinomatosis)
10/2020 - 12/2000
6Rheumatoid Arthritis
01/2011 - 10/2000
6Pain (Aches)
06/2009 - 09/2000
6Type 2 Diabetes Mellitus (MODY)
09/2002 - 01/2000
5Esophageal Neoplasms (Esophageal Cancer)
06/2017 - 01/2000
5Pituitary Neoplasms (Pituitary Adenoma)
05/2014 - 01/2000
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2011 - 01/2000
5Adenoma (Adenomas)
02/2008 - 01/2000
5Leukemia
07/2001 - 01/2000
5Glioblastoma (Glioblastoma Multiforme)
01/2001 - 01/2000
4Neoplasm Metastasis (Metastasis)
01/2021 - 01/2000
4Hypertrophy
03/2015 - 12/2003
4Melanoma (Melanoma, Malignant)
09/2011 - 08/2000
4Hyperplasia
11/2009 - 07/2000
4Diabetic Retinopathy (Retinopathy, Diabetic)
02/2009 - 03/2000
4Seizures (Absence Seizure)
01/2009 - 10/2000
4Granuloma
12/2008 - 06/2001
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2001 - 01/2000
4Brain Neoplasms (Brain Tumor)
07/2001 - 03/2000
4Blister (Bulla)
02/2001 - 08/2000
4Proliferative Vitreoretinopathy
05/2000 - 03/2000
3Insulin Resistance
01/2020 - 01/2000
3Diabetes Mellitus
04/2014 - 12/2001
3Necrosis
06/2009 - 08/2000
3Fibrosis (Cirrhosis)
07/2008 - 02/2000
3Chronic Kidney Failure (Chronic Renal Failure)
02/2008 - 12/2001
3Parkinson Disease (Parkinson's Disease)
01/2008 - 01/2001
3Endocarditis
09/2003 - 04/2000
3Pulmonary Tuberculosis
02/2002 - 05/2001
3Human Influenza (Influenza)
12/2001 - 11/2000
3Hematologic Neoplasms (Hematological Malignancy)
06/2001 - 03/2000
3Hypersensitivity (Allergy)
06/2001 - 12/2000
3Edema (Dropsy)
01/2001 - 04/2000
3Hypesthesia (Numbness)
12/2000 - 08/2000
3Acute Retinal Necrosis Syndrome
05/2000 - 04/2000
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2010
2Proteinuria
04/2016 - 04/2015
2Thrombocytopenia (Thrombopenia)
04/2014 - 11/2000
2Intracranial Aneurysm (Cerebral Aneurysm)
11/2011 - 03/2004

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
10/2020 - 05/2000
11Proteins (Proteins, Gene)FDA Link
07/2005 - 02/2000
7CytokinesIBA
04/2015 - 03/2000
7Messenger RNA (mRNA)IBA
01/2011 - 04/2000
7DNA (Deoxyribonucleic Acid)IBA
11/2002 - 01/2000
6Insulin (Novolin)FDA Link
01/2020 - 01/2000
5AutoantibodiesIBA
09/2014 - 01/2000
5Glucose (Dextrose)FDA LinkGeneric
04/2014 - 01/2000
5Adrenocorticotropic Hormone (ACTH)FDA Link
11/2001 - 01/2000
5EnzymesIBA
08/2001 - 01/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 11/2000
4Dihydrotachysterol (AT 10)IBA
06/2008 - 04/2000
4Adrenal Cortex Hormones (Corticosteroids)IBA
03/2006 - 11/2000
4Biological ProductsIBA
09/2000 - 01/2000
3Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2015 - 03/2000
3Indicators and Reagents (Reagents)IBA
09/2011 - 03/2001
3Formaldehyde (Formol)FDA Link
06/2009 - 01/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2009 - 01/2001
3InterferonsIBA
07/2008 - 02/2000
3SteamIBA
08/2007 - 09/2003
3Platelet-Derived Growth FactorIBA
05/2006 - 05/2000
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2002 - 09/2000
3Complementary DNA (cDNA)IBA
06/2002 - 05/2000
3SteroidsIBA
12/2001 - 04/2000
3Capsules (Microcapsules)IBA
11/2001 - 09/2000
3AcidsIBA
09/2001 - 08/2001
3Codon (Codons)IBA
07/2001 - 01/2000
2Nylons (Nylon)IBA
03/2017 - 06/2014
2Biomarkers (Surrogate Marker)IBA
12/2014 - 05/2001
2Nitric Oxide Synthase (NO Synthase)IBA
05/2014 - 10/2001
2AntigensIBA
03/2014 - 01/2001

Therapy/Procedure

29Therapeutics
09/2010 - 01/2000
11Drug Therapy (Chemotherapy)
10/2020 - 01/2000
7Thoracotomy
06/2017 - 01/2000
5Transplantation
04/2014 - 03/2000
5Renal Dialysis (Hemodialysis)
02/2008 - 08/2001
4Radiotherapy
01/2020 - 01/2001
4Esophagectomy
06/2017 - 06/2000
4Liver Transplantation
04/2014 - 02/2003
4Aftercare (After-Treatment)
11/2011 - 05/2000
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2007 - 05/2000
4Cardiopulmonary Bypass (Heart-Lung Bypass)
12/2002 - 05/2000
3Kidney Transplantation
10/2018 - 01/2009
3Resistance Training
03/2015 - 12/2003
3Lymph Node Excision (Lymph Node Dissection)
11/2010 - 03/2001
3Stents
06/2009 - 10/2002
3Hematopoietic Stem Cell Transplantation
11/2007 - 06/2001
3Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
11/2005 - 04/2001
3Surgical Portasystemic Shunt (Portosystemic Shunt)
05/2005 - 05/2000
3Lasers (Laser)
09/2001 - 08/2000
2Gastrectomy
11/2020 - 06/2007
2Catheters
06/2017 - 07/2003
2Hepatectomy
11/2015 - 01/2001